Literature DB >> 1403677

Pharmacokinetics and pharmacodynamics in the design of controlled-release beads with acetaminophen as model drug.

M Hossain1, J W Ayres.   

Abstract

Relationships between pharmacodynamics (drug concentration and effect) and pharmacokinetics were used to develop an oral, controlled-release-bead dosage form. Reported pharmacodynamic data were used with pharmacokinetic curves to identify effective therapeutic drug concentrations for optimum therapy for a drug with a "deep tissue" effective compartment. The commonly used, over-the-counter, non-narcotic, analgesic-antipyretic acetaminophen (APAP) was used as the model drug. Data reported in the literature were used to compare analgesic and antipyretic efficacy. Computer simulations were performed with MAXSIM (version 3.01) to suggest a zero-order drug release useful for a 12-h, oral, sustained-dosage form for antipyretic therapy in children, on the basis of current pediatric dosing of APAP. Coated APAP beads with the desired release rate were then developed with fluid-bed coating technology.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1403677     DOI: 10.1002/jps.2600810511

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  6 in total

Review 1.  Pharmacokinetic-pharmacodynamic relationships in phase I/phase II of drug development.

Authors:  A Van Peer; E Snoeck; M L Huang; J Heykants
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Jan-Mar       Impact factor: 2.441

2.  Analgesic efficacy of sustained release paracetamol in patients with osteoarthritis of the knee.

Authors:  T H Bacon; J G Hole; M North; I Burnett
Journal:  Br J Clin Pharmacol       Date:  2002-06       Impact factor: 4.335

3.  Selection of 12-Hour Sustained-Release Acetaminophen (Paracetamol) Formulation Through Comparison of Pharmacokinetic Profiles of 4 Sustained-Release Prototype Formulations and Standard Acetaminophen Formulation: An Open-Label, Randomized, Proof-of-Principle Pharmacokinetic Study.

Authors:  Yong Yue; Dongzhou J Liu
Journal:  Clin Pharmacol Drug Dev       Date:  2017-08-16

4.  Evaluation of a 12-Hour Sustained-Release Acetaminophen (Paracetamol) Formulation: A Randomized, 3-Way Crossover Pharmacokinetic and Safety Study in Healthy Volunteers.

Authors:  Yong Yue; Agron Collaku; Dongzhou J Liu
Journal:  Clin Pharmacol Drug Dev       Date:  2017-08-16

5.  Bioequivalence and Safety of Twice-Daily Sustained-Release Paracetamol (Acetaminophen) Compared With 3- and 4-Times-Daily Paracetamol: A Repeat-Dose, Crossover Pharmacokinetic Study in Healthy Volunteers.

Authors:  Dongzhou J Liu; Agron Collaku
Journal:  Clin Pharmacol Drug Dev       Date:  2017-08-16

6.  Efficacy and safety of modified-release paracetamol for acute and chronic pain: a systematic review protocol.

Authors:  Zeljana Margan Koletic; Svjetlana Dosenovic; Livia Puljak
Journal:  BMJ Open       Date:  2019-10-14       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.